Owner Arkion Life Sciences LLC

Inventors Mathre, Owen.; Running, Jeff; Angerer, J. David; Rosson, Reinhardt; Grund, Alan D.; Wassink, Sarah; Deng, MingDe; Jerrell, Jr. Thomas A.; Song, Linsheng; Leanna, Candice; Severson, Dave; Cyron, Don

Agent Freehills

Pub. Number AU-B-2003280305

PCT Number PCT/US2003/0209

PCT Pub. Number WO2004/003175

Priority 60/393,348 01.07.02 US

Filing date 1 July 2003

Wipo publication date 19 January 2004

Acceptance publication date 1 May 2008

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/52 (2006.01) Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12P 19/26 (2006.01) Preparation of compounds containing saccharide radicals

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase